10-K: Aflac 2025 Annual Report: Earnings Dip Amid Investment Losses

Aflac Incorporated reports a 9.3% decline in total revenues and lower net earnings for 2025, primarily driven by significant net investment losses, despite growth in adjusted earnings per share and strong capital ratios.

Summary

• Total revenues decreased 9.3% to $17.2 billion in 2025, compared with $18.9 billion in 2024, primarily due to net investment losses.
• Net earnings were $3.6 billion, or $6.82 per diluted share, for 2025, down from $5.4 billion, or $9.63 per diluted share, in 2024.
• Net investment losses totaled $572 million in 2025, a significant shift from net investment gains of $1.3 billion in 2024.
• Adjusted earnings for 2025 were $4.0 billion, or $7.49 per diluted share, a slight decrease from $4.1 billion, or $7.21 per diluted share, in 2024.
• The stronger yen/dollar exchange rate in 2025 (average 149.32) positively impacted adjusted earnings per diluted share by $0.04.
• Aflac Incorporated repurchased $3.5 billion, or 33.0 million, of its common shares in 2025.
• Shareholders' equity increased to $29.5 billion, or $56.85 per share, at December 31, 2025, from $26.1 billion, or $47.45 per share, at December 31, 2024.
• A cyber incident in June 2025 involved unauthorized access and exfiltration of personal information relating to approximately 22.65 million individuals in the U.S. business, though it is not currently believed to have a material financial impact.
• Aflac Japan's pretax adjusted earnings decreased 1.5% (2.7% in yen terms) in 2025, while Aflac U.S. pretax adjusted earnings were essentially flat.
• Aflac Japan's new annualized premium sales increased 16.0% in yen terms in 2025, driven by new cancer insurance product 'Miraito' and 'Tsumitasu'.
• Aflac U.S. new annualized premium sales increased 3.0% in 2025, primarily due to sales of group products.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a mixed report. While net earnings and total revenues declined due to investment losses, adjusted earnings per share grew, and the company demonstrated strong capital management through share repurchases and increased dividends. Operational segments show resilience and strategic growth initiatives.

Positives

• Adjusted earnings per diluted share increased to $7.49 in 2025 from $7.21 in 2024.
• Shareholders' equity increased to $29.5 billion ($56.85 per share) at December 31, 2025, from $26.1 billion ($47.45 per share) at December 31, 2024.
• The company demonstrated strong capital deployment by repurchasing $3.5 billion (33.0 million shares) of its common stock in 2025.
• The board of directors announced a 5.2% increase in the quarterly cash dividend, effective with the first quarter of 2026.
• Aflac Japan's new annualized premium sales increased 16.0% in Japanese yen terms in 2025, driven by successful new product launches like 'Miraito' and 'Tsumitasu'.
• Aflac U.S. new annualized premium sales increased 3.0% in 2025, primarily driven by growth in group products.
• Aflac Japan's Solvency Margin Ratio (SMR) remains robust at 995% at December 31, 2025, indicating strong financial strength.
• Aflac Japan's estimated Economic Solvency Ratio (ESR) was above the target range of 170% to 230% at December 31, 2025.
• Aflac U.S. combined Risk-Based Capital (RBC) ratio was estimated to be 570% at December 31, 2025, well above regulatory requirements.
• Aflac Japan received certification for the eighth consecutive year as one of the top 500 Leading Companies in Health and Productivity Management.
• Aflac Heartful Services Co., Ltd., a subsidiary of Aflac Japan, actively promotes the hiring of employees with disabilities, with 124 out of 158 employees having a disability as of December 31, 2025.

Negatives

• Total revenues decreased 9.3% to $17.2 billion in 2025 from $18.9 billion in 2024.
• Net earnings decreased significantly to $3.6 billion ($6.82 per diluted share) in 2025 from $5.4 billion ($9.63 per diluted share) in 2024.
• The company experienced net investment losses of $572 million in 2025, a substantial negative swing from net investment gains of $1.3 billion in 2024.
• Adjusted net investment income for Aflac Japan decreased primarily due to lower floating rate income from U.S. dollar-denominated investments.
• Adjusted net investment income for Aflac U.S. decreased primarily due to lower floating rate income.
• Aflac Japan's Solvency Margin Ratio (SMR) decreased to 995% at December 31, 2025, from 1,221% at December 31, 2024.
• Aflac U.S. combined Risk-Based Capital (RBC) ratio decreased to 570% at December 31, 2025, from 677% at December 31, 2024.
• A cyber incident in June 2025 involved unauthorized access and exfiltration of personal information for approximately 22.65 million individuals in the U.S. business.
• Compensation and benefit expense increased to $2.1 billion in 2025 from $2.0 billion in 2024.
• Total adjusted expenses for Corporate and other increased primarily due to higher costs related to business operations, including the ongoing response to the cybersecurity incident and associated legal and professional services.

Risks

• Difficult conditions in global capital markets and the economy, including inflation, could materially adversely affect investments, capital position, revenue, profitability, and liquidity.
• Defaults and credit downgrades of investments, particularly in commercial real estate and highly leveraged companies, may reduce earnings and capital position.
• Global fluctuations in interest rates and exposure to significant interest rate risk, including the impact of low interest rates in Japan and rising rates in the U.S., could adversely affect results.
• Concentration of business in Japan (53% of total adjusted revenues and 76% of total assets in 2025) poses risks related to Japan's economy, market volatility, and sovereign credit profile.
• Limited availability of acceptable Japanese yen-denominated investments could adversely affect results, financial position, or liquidity, leading to reliance on U.S. dollar-denominated investments and associated foreign currency exposure and hedging costs.
• Foreign currency fluctuations in the yen/dollar exchange rate can cause significant earnings and capital volatility.
• Interruption in telecommunication, information technology, and other operational systems, or a failure to maintain the security, confidentiality, integrity, or privacy of sensitive data, could harm the business, as evidenced by the June 2025 cyber incident.
• As a holding company, the Parent Company depends on the ability of its subsidiaries to transfer funds to it, which is subject to regulatory restrictions and financial performance.
• The company's risk management policies and procedures may prove to be ineffective and leave it exposed to unidentified or unanticipated risks.
• Operational risks of third-party vendors, including cybersecurity breaches and disruptions, could lower revenues, increase costs, or damage reputation.
• Tax rates applicable to the company may change, potentially increasing corporate taxes and reducing earnings.
• Failure to comply with restrictions on customer privacy and information security could materially adversely affect reputation and business operations, leading to fines or litigation.
• Extensive regulation and changes in legislation can impact profitability and growth, increasing compliance costs and potentially limiting business expansion.
• Competition could adversely affect the company's ability to increase or maintain its market share or profitability, especially from new entrants or major medical carriers bundling products.
• Catastrophic events, including those related to climate change, epidemics, pandemics, war, or terrorism, could adversely affect financial condition, operations, and infrastructure.
• Events, including those external to the company's operations, could damage the company's reputation, impacting consumer trust and ability to attract sales associates.
• The company depends heavily on key management personnel, and the loss of services of one or more key executives could harm the business.
• Changes in accounting standards issued by the FASB or other standard-setting bodies may adversely affect the company's financial statements.
• The company faces risks related to litigation, regulatory investigations, and inquiries, which could harm its reputation, result in fines, or significantly impact financial results.
• Allegations or determinations of worker misclassification in the United States could adversely affect results of operations, financial condition, and liquidity, potentially leading to changes in the U.S. business model, fines, or litigation.

Future Outlook

The company's strategy for 2026 is to drive long-term shareholder value by pursuing growth and maintaining solid pretax profit margins while exercising tactical capital deployment. This includes product development, distribution expansion, and enhanced efficiency through technological upgrades and operational refinement. Aflac Japan expects a benefit ratio of 60% to 63% and an expense ratio of 20% to 23%. Aflac U.S. anticipates a benefit ratio of 48% to 52% and an expense ratio of 36% to 39%. The company is committed to strong capital ratios and shareholder dividends, with a 5.2% increase in the quarterly cash dividend effective Q1 2026, and targets an Economic Solvency Ratio (ESR) of 170% to 230% for Aflac Japan and a combined Risk-Based Capital (RBC) range of 350% to 450% for Aflac U.S.

Management Comments

• "The Company's overarching human capital philosophy is, If you take care of your employees, your employees will take care of the business."
• "The Company intends to maintain strong capital ratios in Aflac Japan and Aflac U.S. in support of its commitment to shareholder dividends while remaining tactical in its deployment of capital in the form of share repurchases and opportunistic investments."

Industry Context

StockSavvy.ai notes that Aflac's performance in 2025 reflects broader industry challenges, particularly the impact of global capital market volatility on investment income, a common theme for insurers with large investment portfolios. The continued shift towards supplemental health products in Japan, driven by an aging population and rising healthcare costs, aligns with a demographic trend seen in many developed economies. In the U.S., the competitive landscape is intensifying as major medical carriers enter supplemental product segments, a trend that could pressure Aflac's market share if not effectively countered by its brand recognition and distribution capabilities. The focus on digital platforms and AI integration is consistent with the wider financial services industry's push for technological transformation and efficiency.

Comparison to Industry Standards

• Aflac Incorporated's stock performance (278.50) significantly outperformed the S&P 500 (196.16) and the S&P 500 Life and Health Insurance Index (201.00) over the five-year period ending December 31, 2025, starting from a base of 100.00 on December 31, 2020.
• This indicates strong relative performance compared to both the broader market and its direct industry peers, which include Globe Life Inc., MetLife, Inc., Principal Financial Group, Inc., and Prudential Financial, Inc.

Management Changes

Corporate Governance

Legal Proceedings

• The company is a defendant in various lawsuits and receives regulatory inquiries considered to be in the normal course of business, with the outcome of pending litigation not expected to have a material adverse effect on its financial position, results of operations, or cash flows.
• The June 2025 cyber incident has led to questions from regulators and pending disputes, with the potential amount of loss not reasonably estimable at this time.

Related Party Transactions

• The J&A Alliance Trust, associated with Japan Post Holdings Co., Ltd., held 20% of the voting power of the Parent Company's common stock as of May 10, 2024, and 52.3 million shares as of December 31, 2025, representing a significant strategic alliance and shareholder relationship.
• Internal reinsurance transactions with Aflac Re Bermuda Ltd. are conducted, where Aflac Japan cedes policies to Aflac Re, which are eliminated in consolidation except for foreign currency accounting effects.

Stakeholder Impact

• Shareholders: Impacted by decreased net earnings and total revenues, but also benefit from increased dividends (5.2% increase announced) and substantial share repurchases ($3.5 billion in 2025). The cyber incident introduces reputational and potential future financial risks.
• Employees: Affected by changes in U.S. pension plans (frozen, settlement charges), 401(k) contributions, and share-based compensation. Personal information of employees was exfiltrated during the cyber incident.
• Customers: Directly impacted by the cyber incident involving the exfiltration of personal information (claims, health, social security numbers). New product launches in Japan ('Miraito', 'Anshin Palette') aim to address evolving customer needs.
• Regulators: Ongoing engagement and scrutiny, particularly regarding the cyber incident and compliance with various financial and privacy regulations across Japan, the U.S., and Bermuda.
• Distribution Partners: The company's sales networks (independent associates, brokers, and alliance partners like Japan Post Group) are critical for sales and growth, and their effectiveness directly impacts the company's market reach and premium generation.

Next Steps

• The initial report on Aflac Japan's Economic Solvency Ratio (ESR) will be issued as of March 31, 2026.
• The first quarter 2026 cash dividend of $0.61 per share is payable on March 2, 2026.
• The company plans to continue developing and implementing improvements in information technology systems and executing revenue growth and expense management initiatives.
• The company intends to maintain strong capital ratios in Aflac Japan and Aflac U.S.
• The company will continue tactical deployment of capital in the form of share repurchases and opportunistic investments.

Key Dates

Recommendation

Aflac's 2025 results present a mixed picture. While net earnings and total revenues declined significantly due to investment losses, adjusted earnings per share showed growth, and the company maintained strong capital ratios and continued its commitment to shareholder returns through increased dividends and substantial share repurchases. The cyber incident introduces an unquantified risk, but management believes it's not materially impactful. The underlying business segments in Japan and the U.S. are pursuing strategic growth initiatives and product innovation. Given the strong capital position and ongoing shareholder returns, but also the significant drop in GAAP earnings and the lingering cyber risk, a 'Hold' recommendation is appropriate for investors to monitor the execution of strategic initiatives and the resolution of the cyber incident's full impact.

Keywords

Insurance, Supplemental Health, Life Insurance, Japan, United States, Financial Protection, Cancer Insurance, Medical Insurance, Corporate Governance, Risk Management, Cybersecurity, Investment Management, Share Repurchase, Dividends, SEC Filing, 10-K, Aflac